about
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates includ...
Read More
14.55
-0.52
(-3.45%)
253.8K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mesoblast Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..